HERO: A Multinational Phase 3, Randomized, Open-label, Parallelgroup Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer

UCI-17-48
NCT03085095
Cancer - Prostate
Edward Uchio
Open
Treatment
III
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.